Galera Therapeutics (GRTX)
OTHER OTC:GRTX
US Market
Holding GRTX?
Track your performance easily

Galera Therapeutics (GRTX) Financial Statements

260 Followers

Galera Therapeutics Financial Overview

Galera Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.589; its P/E ratio is -0.13; Galera Therapeutics is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -4.06M$ -4.38M$ -4.88M$ -12.99M$ -16.31M
EBITDA$ -4.06M$ -4.37M$ -4.67M$ -12.97M$ -16.30M
Net Income Common Stockholders$ -4.06M$ -4.38M$ -5.59M$ -10.90M$ -20.71M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 10.75M$ 13.47M$ 18.26M$ 28.36M$ 38.76M
Total Assets$ 16.38M$ 19.65M$ 26.14M$ 37.78M$ 48.28M
Total Debt$ 1.19M$ 1.21M$ 1.25M$ 1.29M$ 1.32M
Net Debt$ -9.55M$ -12.25M$ -17.01M$ -27.08M$ -37.43M
Total Liabilities$ 154.41M$ 154.34M$ 157.33M$ 164.33M$ 163.28M
Stockholders Equity$ -138.03M$ -134.69M$ -131.19M$ -126.55M$ -114.95M
Cash Flow-
Free Cash Flow$ -2.72M$ -4.79M$ -9.92M$ -12.52M$ -10.80M
Operating Cash Flow$ -2.72M$ -4.79M$ -9.91M$ -12.52M$ -10.75M
Investing Cash Flow--$ 3.98M$ 10.46M$ 7.55M
Financing Cash Flow--$ -232.00K$ 2.13M$ 1.81M
Currency in USD

Galera Therapeutics Earnings and Revenue History

Galera Therapeutics Debt to Assets

Galera Therapeutics Cash Flow

Galera Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis